| |
|

November 2020 Vol. 8 No.11
Other viewing option
Abstract
Full text
Reprint (PDF) (137 KB)
Search Pubmed for articles by:
Thanasas
I
Paraskevis
D
Other links:
PubMed Citation
Related articles in PubMed
|
|
Merit Research Journal of Medicine and Medical
Sciences (ISSN: 2354-323X) Vol. 8(11) pp.
665-672,
November, 2020
Copyright © 2020 Author(s) retain the copyright
of this article
DOI: 10.5281/zenodo.4293790 |
|
Review
Epidemiology of the HPV in
Greece and other Countries of the World |
|
| |
| |
|
Ioannis Thanasas1*,
Giagkos Lavranos2,
Pinelopi Gogou3,
Dimitrios Paraskevis4 |
|
|
1Department of Obstetrics and
Gynecology, General Hospital in Trikala, Trikala, Greece
2Medical School and Department of Health Sciences,
European University Cyprus, Nicosia, Cyprus
3Clinical Oncology Department, Norwich University
Hospital, UK
4Department of Hygiene Epidemiology and Medical
Statistics, Medical School, National and Kapodistrian University
of Athens, Athens, Greece
*Corresponding Authors Email: thanasasg@hotmail.com
Tel: 00302431029103 / 00306944766469
Received: 09 October 2020 I Accepted:
02 November 2020
I Published: 28 November 2020 I Article ID:
MRJMMS-20-173
Copyright © 2020 Author(s) retain the
copyright of this article.
This article is published under the terms of the
Creative Commons Attribution
License 4.0. |
|
|
Abstract |
|
|
Cervical cancer is
the fourth most common type of cancer among women worldwide. It
is estimated that more than half a million women are infected by
an HPV genotype. The purpose of the epidemiological review is to
determine the prevalence of human papillomavirus (HPV) infection
and the distribution of its genotypes among various countries
worldwide, as well as in Greece and to record the
characteristics of the subtype incidence. We recorded published
studies concerning epidemiological data of the prevalence of the
HPV subtypes, according to the geographical location and HPV
detection rates for both healthy and infected women. The studies
were heterogeneous with regard to sample selection. The
prevalence of any subtype of the HPV is about 11%. HPV16 is the
most common genotype reported in most countries. The substantial
differences in the prevalence and distribution of the virus
among the various geographical sites, deserve further analysis
in global epidemiological studies, including populations with
common characteristics.
Keywords: Developing countries, Developed countries,
Greece, HPV, Prevalence
|
|
|
|